EXPRESSION OF THE P53 PROTEIN IN A SPECTRUM OF ASTROCYTIC TUMORS

被引:41
作者
ELLISON, DW
GATTER, KC
STEART, PV
LANE, DP
WELLER, RO
机构
[1] UNIV SOUTHAMPTON,DEPT NEUROPATHOL,SOUTHAMPTON SO9 5NH,HANTS,ENGLAND
[2] UNIV OXFORD,NUFFIELD DEPT PATHOL,OXFORD,ENGLAND
[3] UNIV DUNDEE,DEPT BIOCHEM,CANC RES CAMPAIGN LABS,DUNDEE DD1 4HN,SCOTLAND
关键词
ASTROCYTOMA; GLIOBLASTOMA; P53; IMMUNOCYTOCHEMISTRY;
D O I
10.1002/path.1711680408
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Many human cancers are characterized by mutations of p53, a nuclear phosphoprotein which controls elements of the cell cycle. Turnover of p53 in normal cells is rapid, and the minute quantities of protein that are usually present are not detected by immunocytochemical methods. Mutations of the p53 gene in tumour cells are associated with a slower turnover and subsequent accumulation of the protein in both nucleus and cytoplasm. Genetic abnormalities of the short arm of chromosome 17, which is the site of the p53 gene locus, are a feature of astrocytic tumours. Using a panel of five antibodies to p53 and a standard immunocytochemical method, we found detectable quantities of p53 in the cells of 3/16 diffuse astrocytomas, 8/14 anaplastic astrocytomas, and 24/34 glioblastoma multiforme. Progression of one patient's tumour from a diffuse to an anaplastic astrocytoma was characterized by the accumulation of p53. The more malignant histological features of anaplastic astrocytoma and glioblastoma multiforme appear to be reflected by a greater incidence of p53 accumulation.
引用
收藏
页码:383 / 386
页数:4
相关论文
共 14 条
  • [1] P53 EXPRESSION IN BREAST-CANCER
    CATTORETTI, G
    RILKE, F
    ANDREOLA, S
    DAMATO, L
    DELIA, D
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1988, 41 (02) : 178 - 183
  • [2] THE P53 PROTO-ONCOGENE CAN ACT AS A SUPPRESSOR OF TRANSFORMATION
    FINLAY, CA
    HINDS, PW
    LEVINE, AJ
    [J]. CELL, 1989, 57 (07) : 1083 - 1093
  • [3] FULTS D, 1992, CANCER RES, V52, P674
  • [4] MUTANT P53 - THE COMMONEST GENETIC ABNORMALITY IN HUMAN CANCER
    HARRIS, AL
    [J]. JOURNAL OF PATHOLOGY, 1990, 162 (01) : 5 - 6
  • [5] P53 MUTATIONS IN HUMAN CANCERS
    HOLLSTEIN, M
    SIDRANSKY, D
    VOGELSTEIN, B
    HARRIS, CC
    [J]. SCIENCE, 1991, 253 (5015) : 49 - 53
  • [6] INCREASED EXPRESSION OF MUTANT FORMS OF P53 ONCOGENE IN PRIMARY LUNG-CANCER
    IGGO, R
    GATTER, K
    BARTEK, J
    LANE, D
    HARRIS, AL
    [J]. LANCET, 1990, 335 (8691) : 675 - 679
  • [7] MITOTIC RECOMBINATION OF CHROMOSOME-17 IN ASTROCYTOMAS
    JAMES, CD
    CARLBOM, E
    NORDENSKJOLD, M
    COLLINS, VP
    CAVENEE, WK
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (08) : 2858 - 2862
  • [8] THE P53 TUMOR SUPPRESSOR GENE
    LEVINE, AJ
    MOMAND, J
    FINLAY, CA
    [J]. NATURE, 1991, 351 (6326) : 453 - 456
  • [9] AMPLIFICATION, ENHANCED EXPRESSION AND POSSIBLE REARRANGEMENT OF EGF RECEPTOR GENE IN PRIMARY HUMAN-BRAIN TUMORS OF GLIAL ORIGIN
    LIBERMANN, TA
    NUSBAUM, HR
    RAZON, N
    KRIS, R
    LAX, I
    SOREQ, H
    WHITTLE, N
    WATERFIELD, MD
    ULLRICH, A
    SCHLESSINGER, J
    [J]. NATURE, 1985, 313 (5998) : 144 - 147
  • [10] REARRANGEMENT OF THE P53 GENE IN HUMAN OSTEOGENIC SARCOMAS
    MASUDA, H
    MILLER, C
    KOEFFLER, HP
    BATTIFORA, H
    CLINE, MJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (21) : 7716 - 7719